- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 12.72M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $50.33M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $52.23M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $8.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $8.51M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $11.68M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $11.51M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $75.14M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $75.24M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $101.73M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $98.33M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 12.75M sh |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $7.98M |
| Capex | Q1 2025 · Mar 31, 2024 | $270.57K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $3.88M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $76.12M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $71.42M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.32 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.33 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $3.99M |
| Rd Expense restated | Q1 2025 · Mar 31, 2024 | $821K |
| Net Income | Q1 2025 · Mar 31, 2024 | $4.14M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $4.75M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $13.39M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $4.21M |
| Revenue | Q1 2025 · Mar 31, 2024 | $17.6M |